Exceeding Your Benchmark – Benchmark Products

Pharma Manufacturing: Meeting Annex I with Precision Machining for Safer Sterile Drug Production

precision machining

Pharmaceutical manufacturers are under increasing pressure to deliver sterile, high-quality medicines in smaller batches and faster cycles. As pharma manufacturing evolves, regulatory demands have intensified, especially following the 2023 revision of EU GMP Annex I, which places new emphasis on contamination control strategies, improved traceability, and minimizing human intervention throughout production. According to American…

Read More

Latest

Benchmark Products
Sterile Compounding and Contamination Control with Abby Roth

In this episode of Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Abby Roth, founder of Pure Microbiology, about sterile compounding and contamination control. Abby shares her expertise in microbiology, sterile environments, and best practices in pharmaceutical compounding. The conversation begins with a distinction between traditional drug manufacturing and sterile compounding, highlighting the…

Read More
Benchmark Products
One Year of The Exceeding Your Benchmark Podcast

Benchmark Products provides products for critical life science and pharma environments. In this podcast series Exceeding Your Benchmark, they interview leading experts on a variety of trending topics. In celebration of its first year, Exceeding Your Benchmark looks back at interviews with experts from life science and pharmaceutical manufacturing on timely topics from Annex…

Read More
Exceeding Your Benchmark - Benchmark Products
Exploring the Fundamentals of Validation in Life Science Manufacturing

In the rapidly evolving domain of life science manufacturing, validation emerges as a cornerstone to ensure that products meet stipulated requirements concerning quality, safety, and efficacy. This pivotal aspect of manufacturing comes to focus as regulatory landscapes shift, mandating stringent compliance to ensure patient safety. In a recent episode of Exceeding Your Benchmark, a…

Read More
Articles Healthcare
Pharmaceutical Manufacturing is Witnessing Major Transformation as New Demands for Sterility Assurance Reshape Healthcare

For an industry where precision and quality control are paramount, pharmaceutical manufacturing is witnessing an evolutionary leap in contamination control practices. Propelled by changes in regulatory environments, such as the EU’s Annex 1 update and ICH Q9 focusing on quality risk management, the sector is shifting from isolated, data-point-centric strategies towards a more holistic…

Read More
Exceeding Your Benchmark - Benchmark Products
Connecting Data to Improve Your Contamination Control Strategies

Contamination control is absolutely critical in the pharmaceutical industry and includes particulate, microbial, product carryover, chemical, and viral aspects of contamination and often involves proactive, reactive, and supporting aspects. However, regulations, liabilities, and patient health added to the mix create data silos that often form multiple processes and make it difficult to create efficient and…

Read More
Exceeding Your Benchmark - Benchmark Products
Revolutionizing the Audit Process: Advancements in Supplier Assessments Within the Pharmaceutical Sector

Pharmaceutical companies invest significant resources in research and development to discover new drugs and therapies and improve existing ones. This involves rigorous testing, clinical trials, and obtaining regulatory approval before a drug can be sold. Government agencies, such as the Food and Drug Administration (FDA) in the United States, oversee the approval process and conduct…

Read More

Latest

telecom
Predictive Networks: How Baron Weather and GIS are Strengthening Telecom Operations
February 12, 2026

Severe weather is no longer an occasional disruption for telecom providers—it’s becoming part of the operating environment. During Hurricane Ida in 2021, the Federal Communications Commission reported that nearly 1,000 cell sites across Louisiana and Mississippi went offline. In 2024, Hurricane Milton left more than 12% of cell sites in impacted areas of Florida…

Read More
The DAISY Foundation: Impacting Nurse Careers Through Recognition
The DAISY Foundation: Impacting Nurse Careers Through Recognition
February 12, 2026

Recognition is often described as a “nice to have” in healthcare, but on this episode of Care Anywhere, it’s framed as something far more essential. Host Lea Sims sits down with Deb Zimmermann, DNP, RN, NEA-BC, FAAN, Chief Executive Officer of The DAISY Foundation, and Bonnie Barnes, FAAN, co-founder of the organization, to explore…

Read More
Revpar Media
The Origin of Revpar Media: Host Calvin Tilokee’s Journey from Revenue Management to Performance Storytelling
February 11, 2026

Something has shifted in hotel marketing, and you can feel it. In a landscape where every property can publish polished visuals, aesthetics alone are no longer enough to stand out—or to convert attention into bookings. Research increasingly shows that social media now plays a meaningful role in how travelers choose destinations and plan trips,…

Read More
spiral growth
Spiral Growth: The Career Strategy That Builds Real Leaders
February 11, 2026

Leadership pipelines are under pressure. Companies are moving faster, roles are becoming more cross-functional, and high-potential talent is expected to deliver beyond narrow job descriptions earlier in their careers. At the same time, the World Economic Forum estimates that 39% of workers’ core skills will need to evolve by 2030 to keep pace with…

Read More
Other Exceeding Your Benchmark - Benchmark Products
How Life Science Manufacturing Facilities Can Successfully Adapt To Change
February 11, 2023

In this podcast episode of “Exceeding Your Benchmark,” host Gabrielle is joined by Ashley Harp, Lead Process Engineer at CRB. They discuss the challenges manufacturing facilities like Life Science Companies are facing as they adapt to new technologies and advancements in manufacturing, specifically in the area of combining highly potent active pharmaceutical ingredients (HPAPIs) and…

Read More
How Cell and Gene Manufacturers Can Scale to Meet Demand
December 21, 2022

Between 2022 and 2030, the cell and gene therapy sector is expected to experience a compound annual growth rate (CAGR) of 39.42 percent, BioSpace said of a recent Vision Research Report. This is quite a large anticipated growth; how will startups and current manufacturing companies work to meet this growing demand? On today’s episode of…

Read More
What Updated Annex 1 Regulations Mean for Sterile Manufacturing Companies in 2023
November 2, 2022

Over the summer new GMP Annex 1 regulations were released by the FDA and EMA, prompting new changes to become standard protocolin sterile manufacturing companies. By August 2023, the regulations will take effect and companies will have to ensure that they are in compliance with the guidelines set. Discussing this on a new podcast, host…

Read More